News

Patients with chronic spontaneous urticaria experience inadequate symptom control and significant emotional burdens despite ...
B oth men and women with psoriasis are equally at risk for developing psoriatic arthritis (PsA)-a chronic inflammatory ...
Researchers have established that smoking tobacco has a high likelihood of increasing the risk of relapse in patients ...
Cytokine networks demonstrate dual functionality. Cytokines are key regulators of immune homeostasis, but paradoxically, cytokines also function as pathogenic drivers in diseases such as systemic ...
Icotrokinra is a first-in-class targeted oral peptide that blocks interleukin (IL) 23 and its receptor, which plays a key ...
Bristol Myers Squibb said the U.S. Food and Drug Administration has accepted its application seeking expanded approval of its plaque psoriasis drug Sotyktu for the treatment of adults with active ...
Medically reviewed by Anita C. Chandrasekaran, MD Every person experiences psoriatic arthritis (PsA) differently, but if you have this chronic inflammatory condition, your feet will likely be affected ...
Discover a study showing low and stable cancer risk in patients with PsO, PsA, and axSpA treated long-term with ixekizumab.
Psoriatic arthritis (PsA) is less common among Black people compared to other races, but differences in prevalence may also ...
New research identifies diabetes as an independent predictor of major adverse cardiovascular events in patients with both ...
On behalf of our sponsors at Arcutis Biotherapeutics, we're learning more about Plaque Psoriasis, the chronic, inflammatory skin disease that affects many people and a new topical treatment that may ...
Guselkumab and risankizumab for psoriasis have the highest rates of drug survival among biologics measured and a comparable safety profile.